CINI, MICHELA
 Distribuzione geografica
Continente #
NA - Nord America 2.397
AS - Asia 1.329
EU - Europa 1.186
SA - Sud America 104
AF - Africa 67
OC - Oceania 1
Totale 5.084
Nazione #
US - Stati Uniti d'America 2.374
SG - Singapore 506
CN - Cina 394
GB - Regno Unito 385
VN - Vietnam 172
DE - Germania 167
IT - Italia 119
SE - Svezia 111
HK - Hong Kong 110
BR - Brasile 84
RU - Federazione Russa 84
FR - Francia 77
IN - India 71
IE - Irlanda 51
UA - Ucraina 51
NL - Olanda 47
ZA - Sudafrica 38
EE - Estonia 34
JP - Giappone 26
BE - Belgio 16
FI - Finlandia 15
KR - Corea 15
SC - Seychelles 15
AR - Argentina 10
CA - Canada 10
CI - Costa d'Avorio 9
MX - Messico 8
CH - Svizzera 7
JO - Giordania 6
ID - Indonesia 5
AT - Austria 4
GR - Grecia 4
RO - Romania 4
SA - Arabia Saudita 4
BD - Bangladesh 3
CO - Colombia 3
IQ - Iraq 3
MY - Malesia 3
PL - Polonia 3
TR - Turchia 3
CL - Cile 2
IL - Israele 2
PA - Panama 2
PE - Perù 2
TG - Togo 2
UY - Uruguay 2
UZ - Uzbekistan 2
AE - Emirati Arabi Uniti 1
AU - Australia 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
EC - Ecuador 1
ES - Italia 1
GT - Guatemala 1
HN - Honduras 1
HR - Croazia 1
HU - Ungheria 1
LB - Libano 1
LT - Lituania 1
MA - Marocco 1
NO - Norvegia 1
PH - Filippine 1
SN - Senegal 1
TN - Tunisia 1
Totale 5.084
Città #
Fairfield 356
Singapore 343
Southend 335
Ashburn 185
Santa Clara 183
Chandler 177
Woodbridge 158
Houston 141
Cambridge 136
Wilmington 136
Seattle 126
Hong Kong 107
Ann Arbor 103
Princeton 79
Beijing 55
Dallas 53
Dublin 51
Hefei 51
Nanjing 51
Boardman 47
Dong Ket 44
Ho Chi Minh City 42
Padova 37
Westminster 37
Hanoi 28
Berlin 25
Shenyang 25
Tokyo 24
Los Angeles 23
Dearborn 22
Jacksonville 22
Jinan 22
Turin 21
Buffalo 20
Saint Petersburg 18
Brussels 16
Hebei 16
Bologna 15
San Diego 15
Seoul 15
Helsinki 12
Changsha 10
Frankfurt am Main 10
Hangzhou 10
Redondo Beach 10
Abidjan 9
Chicago 9
Milan 9
Zhengzhou 9
Fuzhou 8
Jiaxing 8
São Paulo 8
Haikou 7
Lanzhou 7
Nanchang 7
Amman 6
Guangzhou 6
Norwalk 6
Tianjin 6
Bengaluru 5
Kunming 5
Redmond 5
Yubileyny 5
Bern 4
Bremen 4
Falls Church 4
Mahé 4
Medford 4
Moscow 4
Mülheim 4
New York 4
Nuremberg 4
Olalla 4
Paris 4
San Francisco 4
Xi'an 4
Atlanta 3
Bexley 3
Boston 3
Chongqing 3
Falkenstein 3
London 3
Montreal 3
Ningbo 3
Orem 3
Rio de Janeiro 3
Shanghai 3
Shenzhen 3
Warsaw 3
Wuhan 3
Belo Horizonte 2
Belém 2
Brooklyn 2
Buenos Aires 2
Bühl 2
Costa Mesa 2
Detroit 2
Düsseldorf 2
Elk Grove Village 2
Guarulhos 2
Totale 3.651
Nome #
Diagnostic Accuracy of a New d -Dimer Assay (Sclavo Auto d -Dimer) for Exclusion of Deep Vein Thrombosis in Symptomatic Outpatients 181
Abnormally short activated partial thromboplastin time values are associated with increased risk of recurrence of venous thromboembolism after oral anticoagulation withdrawal. 178
A new rapid bedside assay for D-dimer measurement (Simplify D-dimer) in the diagnostic work-up for deep vein thrombosis. 174
Age and gender specific cut-off values to improve the performance of D: -dimer assays to predict the risk of venous thromboembolism recurrence. 173
D-dimer for the diagnosis of upper extremity deep and superficial venous thrombosis 156
Poor comparability of coagulation screening test with specific measurement in patients receiving direct oral anticoagulants: results from a multicenter/multiplatform study 152
D-dimer and factor VIII are independent risk factors for recurrence after anticoagulation withdrawal for a first idiopathic deep vein thrombosis. 145
High plasma levels of factor VIII and risk of recurrence of venous thromboembolism 145
D-dimer and residual vein obstruction as risk factors for recurrence during and after anticoagulation withdrawal in patients with a first episode of provoked deep-vein thrombosis. 143
G20210A prothrombin mutation and critical limb ischaemia in patients with peripheral arterial disease. 143
Inherited and acquired thrombophilic alterations in patients with superficial vein thrombosis of lower limbs 143
Evaluation of a chemiluminescent immunoassay, the HemosIL AcuStar D-Dimer, in outpatients with clinically suspected deep venous thrombosis 140
Influence of proband's characteristics on the risk for venous thromboembolism in relatives with factor V Leiden or prothrombin G20210A polymorphisms. 140
Variability of cut-off values for the detection of lupus anticoagulants: results of an international multicenter multiplatform study 137
D-dimer, FVIII and thrombotic burden in the acute phase of deep vein thrombosis in relation to the risk of post-thrombotic syndrome 136
The F11 rs2289252 polymorphism is associated with FXI activity levels and APTT ratio in women with thrombosis. 132
D-dimer use for deep venous thrombosis exclusion in elderly patients: a comparative analysis of three different approaches to establish cut-off values for an assay with results expressed in D-dimer units 131
Thrombotic burden, D-dimer levels and complete compression ultrasound for diagnosis of acute symptomatic deep vein thrombosis of the lower limbs. 130
Rivaroxaban in the Treatment of Heparin-Induced Thrombocytopenia 130
Thrombin generation and intracranial atherosclerotic disease in patients with a transient ischaemic attack 130
A new warfarin dosing algorithm including VKORC1 3730 G > A polymorphism: comparison with results obtained by other published algorithms 129
Oral contraceptive use in women with poor anticoagulant response to activated protein C but not carrying the factor V Leiden mutation increases the risk of venous thrombosis. 128
Measurement of factor XIII (FXIII) activity by an automatic ammonia release assay using iodoacetamide blank-procedure: no more overestimation in the low activity range and better detection of severe FXIII deficiencies 128
Evaluation of a new automated panel of assays for the detection of anti-PF4/heparin antibodies in patients suspected of having heparin-induced thrombocytopenia. 127
Poor anticoagulation quality in the first 3 months after unprovoked venous thromboembolism is a risk factor for long-term recurrence. 126
Thalidomide-dexamethasone as up-front therapy for patients with newly diagnosed multiple myeloma: thrombophilic alterations, thrombotic complications, and thromboprophylaxis with low-dose warfarin. 124
D-dimer levels in combination with residual venous obstruction and the risk of recurrence after anticoagulation withdrawal for a first idiopathic deep vein thrombosis. 121
The influence of VKORC1 3730 G > A polymorphism on warfarin dose: reply. 117
Influence of low-density lipoprotein (LDL) receptor-related protein and ABO blood group genotypes on factor XI levels. 116
Pharmacodynamics of low molecular weight heparin in patients undergoing bariatric surgery: a prospective, randomised study comparing two doses of parnaparin (BAFLUX study). 116
Incidence and clinical outcomes of heparin-induced thrombocytopenia: 11 year experience in a tertiary care university hospital 111
Risk of deep vein thrombosis: interaction between oral contraceptives and high factor VIII levels. 109
Multicenter evaluation of a new quantitative highly sensitive D-dimer assay, the Hemosil D-dimer HS 500, in patients with clinically suspected venous thromboembolism. 105
The Wells rule and D-dimer for the diagnosis of isolated distal deep vein thrombosis 104
Thrombophilic risk factors and peripheral arterial disease severity. 102
No early signs of atherosclerotic alterations in carriers of inherited thrombophilia. 97
Contribution of low density lipoprotein receptor-related protein genotypes to coagulation factor VIII levels in thrombotic women. 88
null 80
The role of D-dimer and residual venous obstruction in recurrence of venous thromboembolism after anticoagulation withdrawal in cancer patients. 65
Venous Thromboembolism in Women of Childbearing Age: Insights from the START Registry 52
Different cut-off values of quantitative D-dimer methods to predict the risk of venous thromboembolism recurrence: a post-hoc analysis of the PROLONG study. 51
Venous Thromboembolism in Women of Childbearing Age: Insights from the START Registry 46
Totale 5.181
Categoria #
all - tutte 13.949
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.949


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021230 0 0 0 0 0 15 14 19 51 27 16 88
2021/2022603 79 32 46 27 62 41 21 43 17 51 61 123
2022/2023649 106 108 26 97 42 49 14 37 84 20 47 19
2023/2024114 5 36 17 8 13 7 5 5 1 4 5 8
2024/2025901 19 152 54 40 250 42 56 7 3 67 13 198
2025/2026878 90 152 193 108 239 96 0 0 0 0 0 0
Totale 5.181